London / Geneva (Reuters) - Guinea vaccine is 100 percent effective as demonstrated by the experience of the World Health Organization, that is about to be able to protect the people against the Ebola virus on Friday.
of the virus in the vaccine and the mark of 4,000 people is VSV-ZEBOV NewLink Genetics ", which tested the trial, 10 days after initial results showed complete protection.
Results "surprising" and by global health experts "change the rules of the game", as has been described.
If it starts in West Africa than in December 2013 that killed 11,200 people in the worst recorded outbreak of Ebola vaccine to help end use.
31 July 2015 (W up to 11 279 27 748, with the death of Ebola was reported ...
World Health Organization Director-General Margaret Chan in the medical journal The Lancet published online the results, "the change in the current Ebola outbreak management and disease outbreaks." Said
Global them to purchase large amounts of vaccines for poor countries who are struggling to buy the alliance, with the support of a shot that he had once Ebola.
"This is an effective vaccine in the community sooner rather than later," said Gavin, CEO Seth Berkley. "We have to be willing to work anywhere is a threat to the virus."
The virus is still spreading, the researchers tested the treatments and vaccines, as raced this and other vaccines experience with a massive international effort has accelerated.
"It was a race against time, and the trial was to be implemented under the most challenging circumstances," Public Health, Norwegian Institute of Trial Steering Group Chairman John Arne Röttingen said.
Ebola suspected of carrying the body of a middle-aged man working in the field of health care ...
"Ring vaccination"
The diagnosis of the vaccine, or at a later date - the trial where they are in close touch with the Ebola virus, the so-called "ring vaccination strategy", to use a single dose of VSV-ZEBOV March 23 to assess the effectiveness and safety to Guinea.
The risks involved in making it unnecessary to wait for the immoral and it became clear that, because the data ", in late strategy", however, researchers will not use it on July 26 decided to include the protection of those who are vaccinated immediately began to appear very high rate.
The World Health Organization now with all participants receiving the vaccine immediately, the trial is continuing, and Walotefal perhaps 6 to 12 years old will be expanded to include 13 to 17-year-old man ..
Jeremy Farrar, director of infectious disease and the judgment of the Wellcome Trust, a leading expert in the field "in the midst of an epidemic in Guinea to assess the vaccine, which uses a highly innovative and practical design dared." he says,
"Our hope is that this vaccine can end the epidemic is now helping to achieve, and that the future inevitably will be available for Ebola outbreak," he said in his speech.
Charities that have broken the chain and the front-line health workers to be transferred to the outbreak, Liberia and Sierra Leone, was the center of education in West Africa for the VSV-ZEBOV fight against the Ebola virus, and which led to the Médecins Sans Frontieres (MSF) ,.
VSV-ZEBOV Mark's responsibility is to study the genetics of NewLink which occurred after delivery, before obtaining a license for the Public Health Agency of Canada was developed by a development and distribution agreement.
Guinea can experience success in this year's vaccine will prove to sabotage his hopes of researchers, many of whom fear a sharp drop in cases, a source of great satisfaction.
Another large trial of Liberia was intended to recruit some 28,000, has to stop recording after reaching the middle of the stage, but that is the goal of 1,500 participants. Plans also been scaled back to Sierra Leone test. To prove the effectiveness of vaccination as the only true hope, Ebola is still infecting new victims in the school in Guinea.
of the virus in the vaccine and the mark of 4,000 people is VSV-ZEBOV NewLink Genetics ", which tested the trial, 10 days after initial results showed complete protection.
Results "surprising" and by global health experts "change the rules of the game", as has been described.
If it starts in West Africa than in December 2013 that killed 11,200 people in the worst recorded outbreak of Ebola vaccine to help end use.
31 July 2015 (W up to 11 279 27 748, with the death of Ebola was reported ...
World Health Organization Director-General Margaret Chan in the medical journal The Lancet published online the results, "the change in the current Ebola outbreak management and disease outbreaks." Said
Global them to purchase large amounts of vaccines for poor countries who are struggling to buy the alliance, with the support of a shot that he had once Ebola.
"This is an effective vaccine in the community sooner rather than later," said Gavin, CEO Seth Berkley. "We have to be willing to work anywhere is a threat to the virus."
The virus is still spreading, the researchers tested the treatments and vaccines, as raced this and other vaccines experience with a massive international effort has accelerated.
"It was a race against time, and the trial was to be implemented under the most challenging circumstances," Public Health, Norwegian Institute of Trial Steering Group Chairman John Arne Röttingen said.
Ebola suspected of carrying the body of a middle-aged man working in the field of health care ...
"Ring vaccination"
The diagnosis of the vaccine, or at a later date - the trial where they are in close touch with the Ebola virus, the so-called "ring vaccination strategy", to use a single dose of VSV-ZEBOV March 23 to assess the effectiveness and safety to Guinea.
The risks involved in making it unnecessary to wait for the immoral and it became clear that, because the data ", in late strategy", however, researchers will not use it on July 26 decided to include the protection of those who are vaccinated immediately began to appear very high rate.
The World Health Organization now with all participants receiving the vaccine immediately, the trial is continuing, and Walotefal perhaps 6 to 12 years old will be expanded to include 13 to 17-year-old man ..
Jeremy Farrar, director of infectious disease and the judgment of the Wellcome Trust, a leading expert in the field "in the midst of an epidemic in Guinea to assess the vaccine, which uses a highly innovative and practical design dared." he says,
"Our hope is that this vaccine can end the epidemic is now helping to achieve, and that the future inevitably will be available for Ebola outbreak," he said in his speech.
Charities that have broken the chain and the front-line health workers to be transferred to the outbreak, Liberia and Sierra Leone, was the center of education in West Africa for the VSV-ZEBOV fight against the Ebola virus, and which led to the Médecins Sans Frontieres (MSF) ,.
VSV-ZEBOV Mark's responsibility is to study the genetics of NewLink which occurred after delivery, before obtaining a license for the Public Health Agency of Canada was developed by a development and distribution agreement.
Guinea can experience success in this year's vaccine will prove to sabotage his hopes of researchers, many of whom fear a sharp drop in cases, a source of great satisfaction.
Another large trial of Liberia was intended to recruit some 28,000, has to stop recording after reaching the middle of the stage, but that is the goal of 1,500 participants. Plans also been scaled back to Sierra Leone test. To prove the effectiveness of vaccination as the only true hope, Ebola is still infecting new victims in the school in Guinea.
